By Paula Connelly
Lately, I can’t help but shake the HPV terror that has descended on girls everywhere. Two types of HPV (out of 40) have been found to cause about 70 percent of cervical cancer and two types have been found to cause about 90 percent of genital warts. Coupled with statistical evidence that over 50 percent of both men and women will contract HPV at some point in their lives and that by age 50, at least 80 percent of women will have been infected with genital HPV infection, there is good cause for alarm. Even though most HPV infections have no symptoms and go away on their own, I’d prefer not to gamble with cancer. And since condoms do not prevent the spread of HPV, I was relieved to learn that Merck & Co., Inc. developed a vaccine called Gardasil to protect against the four strains which lead to cervical cancer and genital warts.
The vaccine is overpriced and difficult to obtain, especially for women over the age of 12, due to the slim chances a normal, sexually active person wouldn’t already have contracted some form of HPV. Currently, the vaccine is only approved for women ages 9 to 26 (problematic for women over 26 facing the statistical leap into the 80 percent of women infected by age 50). But I say, don’t listen to that doomed logic! The fact remains that the vaccine protects against four strains, so having one strain already does not mean you should give up on fighting the rest. There is no treatment for HPV.
Armed with (and scared by) these statistics, I went to my doctor a few months ago, ready to demand they give me the vaccine — and ready to stage all kinds of protests upon my denial. Lucky for them, I was met with great enthusiasm at my desire to get the vaccine at all, and my appointment was promptly scheduled.